Fasenra

FDA Approves Fasenra for Treatment of Eosinophilic Granulomatosis with Polyangiitis
Managed Healthcare Executive
Wed, 09/18/24 - 11:03 pm
AstraZeneca
Fasenra
eosinophilic granulomatosis with polyangiitis
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent
AstraZeneca’s Fasenra asthma drug shows promise for COPD treatment
Biopharma Reporter
Tue, 05/21/24 - 11:27 am
AstraZeneca
COPD
Fasenra
clinical trials
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
BioSpace
Fri, 04/12/24 - 11:15 am
AstraZeneca
Fasenra
severe asthma
FDA
eosinophilic asthma
pediatric
AstraZeneca, working to grow Fasenra’s reach, touts positive trial against GSK's Nucala in new use
Fierce Pharma
Tue, 09/12/23 - 07:10 pm
AstraZeneca
Fasenra
clinical trials
GSK
Nucala
eosinophilic asthma
AstraZeneca’s Fasenra meets primary endpoint in Phase III rare vasculitis trial
Clinical Trials Arena
Tue, 09/12/23 - 10:37 am
AstraZeneca
Fasenra
GSK
Nucala
eosinophilic granulomatosis with polyangiitis
clinical trials
Weak data for Fasenra undermine AZ’s ambitions for the drug
Pharmaphorum
Tue, 10/25/22 - 10:35 am
AstraZeneca
Fasenra
eosinophilic asthma
chronic rhinosinusitis with nasal polyps
eosinophilic esophagitis
AstraZeneca debuts annoying purple ‘Phil’ creatures, personified asthma eosinophils ‘behaving badly’
Endpoints
Wed, 10/5/22 - 10:35 am
pharma marketing
DTC advertising
AstraZeneca
eosinophilic asthma
asthma
Fasenra
FDA says no to AZ’s Fasenra for nasal polyp indication
Pharmaforum
Mon, 03/14/22 - 10:19 am
AstraZeneca
Fasenra
nasal polyps
AstraZeneca's Fasenra spares asthma patients from steroid use in large trial
Fierce Pharma
Thu, 10/29/20 - 12:10 pm
AstraZeneca
asthma
Fasenra
clinical trials
AstraZeneca's asthma drug succeeds late-stage study
Reuters
Thu, 09/10/20 - 10:35 am
AstraZeneca
Fasenra
asthma
nasal polyps
clinical trials
FDA green lights AstraZeneca's asthma drug Fasenra for self-administration
Yahoo/Reuters
Fri, 10/4/19 - 10:25 am
AstraZeneca
FDA
asthma
Fasenra
AstraZeneca’s Fasenra gets FDA ODD status for eosinophilic oesophagitis
Pharmaceutical Business Review
Thu, 08/29/19 - 10:28 am
AstraZeneca
Fasenra
orphan drugs
FDA
eosinophilic esophagitis
AstraZeneca respiratory business gets boost from 3-drug inhaler results
Yahoo/Reuters
Wed, 08/28/19 - 10:52 am
AstraZeneca
Fasenra
Breztri
COPD
AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis
Fierce Pharma
Mon, 05/20/19 - 10:12 am
AstraZeneca
Fasenra
severe asthma
asthma
clinical trials
AstraZeneca’s asthma drug Fasenra looks promising for a set of rare chronic immune diseases
Endpoints
Thu, 04/4/19 - 10:30 am
AstraZeneca
Fasenra
asthma
HES
FDA
Astrazeneca's Fasenra Gets Orphan Drug Designation for Autoimmune Disease
Yahoo/Zacks.com
Tue, 11/27/18 - 12:09 pm
AstraZeneca
Fasenra
orphan drugs
FDA
eosinophilic granulomatosis with polyangiitis
AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data
Fierce Pharma
Tue, 09/18/18 - 10:13 pm
AstraZeneca
COPD
Fasenra
asthma
NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be used
Fierce Pharma
Sun, 07/22/18 - 12:21 pm
AstraZeneca
Fasenra
GSK
Nucala
NICE
asthma
AstraZeneca drug Fasenra fails to achieve main goal in COPD trial
Yahoo/Reuters
Wed, 05/30/18 - 10:21 am
AstraZeneca
Fasenra
COPD
clinical trials

Pages